21. 100PImproved survival of young patients with breast cancer ≤ 40 years of age at diagnosis. (13th May 2019) Authors: Dick, J El; Khalil, L E; Charafeddine, M; Tomb, P El; Fares, J; El Saghir, N S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. 100PPhase II KEYNOTE-164 study of pembrolizumab (pembro) monotherapy for patients (pts) with previously treated, mismatch repair–Deficient (dMMR) advanced colorectal cancer (CRC): Primary and Japan subgroup analyses. (25th November 2018) Authors: Hara, H; Yoshino, T; Taniguchi, H; Akagi, K; Shitara, K; Masuishi, T; Kuboki, Y; Shimamoto, T; Ueki, K; Han, S R; Noguchi, K; Diaz, L A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. 1010PDALK positive anaplastic large cell lymphoma: Molecular diagnosis and minimal residual disease monitoring. (23rd October 2018) Authors: Kalinova, M; Krskova, L; Mrhalova, M; Kabickova, E; Riha, P; Kodet, R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. 1012PDEvaluation of safety, tolerability and efficacy of temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice. (23rd October 2018) Authors: Dreyling, M H; Hess, G; Woike, M; Krekeler, G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. 1013PDA comparative study of 18F-FDG PET/CT with bilateral bone marrow trephine biopsy for assessment of bone marrow infiltration by lymphoma. (23rd October 2018) Authors: Arjunan, D; Prakash, G; Malhotra, P; Varma, N; Varma, S C; Das, A; Mittal, B R; Basher, R; Lad, D; Kumari, S; Khadwal, A R; Vikas, S; Naseem, S; Bal, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. 1013PThe role of FDG-PET/CT in detecting bone marrow involvement in diffuse large b-cell lymphoma. (18th September 2017) Authors: Bulbul, A.; Mino, E.A.; Chouial, S.; Bautista, A.; Mustafa, A.; Abboud, H.; Rashad, S.; Braik, T.; Masoud, K. Journal: Annals of oncology Issue: Volume 28(2017)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. 1018PProgression of disease within 2 years (POD24) is a clinically significant endpoint to identify follicular lymphoma patients with high risk of death. (23rd October 2018) Authors: Sortais, C; Lok, A; Gastinne, T; Mahé, B; Dubruille, V; Blin, N; Howlett, S; Tabah, A; Arnaud, P; Moreau, A; Moreau, P; Leux, C; Le Gouill, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. 1019PImpact of genetic polymorphisms on prognosis and survival of diffuse large B-cell lymphoma. (23rd October 2018) Authors: Novosad, O; Pastushenko, I; Skrypets, T; Tytorenko, I; Kadnikova, T; Skachkova, O; Gorbach, O; Svergun, N; Khranovska, N; Kriachok, I Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. 101P Neoadjuvant chemotherapy for locally advanced breast cancer. (20th December 2016) Authors: Fomenko, Y.; Sirota, V.; Bitz, U.; Zhumakaeva, S.; Omarova, I.; Kabildina, N. Journal: Annals of oncology Issue: Volume 27(2016:Sep.)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. 101P Results of the NLG2105 phase I trial using the IDO pathway inhibitor indoximod, in combination with radiation and chemotherapy, for children with newly diagnosed DIPG. (15th December 2019) Authors: Johnson, T S; Aguilera, D; Al-Basheer, A; Berrong, Z; Castellino, R C; Eaton, B R; Esiashvili, N; Foreman, N; Heger, I M; Kennedy, E P; Vahanian, N; Martin, W; Pacholczyk, R; Ring, E; Sadek, R F; Smith, A; Shimoda, M; Macdonald, T J; Munn, D H Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗